Home β€Ί Stock analysis β€Ί MOLN

Molecular Partners Ag (MOLN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

MOLN dips 2.5% to $3.56, a 6-month low, 5 down days in a row. Closed at $3.56, -2.47% vs the prior close of $3.65. Day range $3.56–$3.71, opened at $3.71.

Last close$3.56-2.47%
Day range3.56–3.71
Open3.71
Volume680
52-week range3.52–5.36
Avg volume (20d)1.53K

MOLN daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” MOLN dips 2.5% to $3.56, a 6-month low, 5 down days in a row
Oct 15, 2026 β€” MOLN ends flat (+0.0%) to $3.65, 4 down days in a row
Oct 14, 2026 β€” MOLN dips 0.5% to $3.65, a 6-month low on 2.6x normal volume
Oct 13, 2026 β€” MOLN slides 3.2% to $3.67, a 6-month low
Oct 12, 2026 β€” MOLN dips 1.6% to $3.79 on 2.6x normal volume
Oct 9, 2026 β€” MOLN rises 1.0% to $3.85 on 4.7x normal volume
Oct 8, 2026 β€” MOLN ends flat (+0.0%) to $3.81
Oct 7, 2026 β€” MOLN rises 0.8% to $3.81
Oct 6, 2026 β€” MOLN slides 3.6% to $3.78, a 3-month low on 4.3x normal volume
Oct 5, 2026 β€” MOLN ends flat (+0.3%) to $3.92
Oct 2, 2026 β€” MOLN ends flat (+0.0%) to $3.91

MOLN latest news & SEC filings

Every SEC filing by or about MOLN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Aug 25, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001745114-26-000028

Jul 20, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-004758

Jul 7, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-004488

Jul 2, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-004433

Jun 24, 2026 Β· Form S-8 β€” Employee share plan registration

Registration of shares for employee stock plans (S-8)

Source: SEC EDGAR filing 0001745114-26-000023

Things to know before you trade MOLN

MOLN market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20263.713.713.563.56680
Oct 15, 20263.653.653.653.650
Oct 14, 20263.673.703.523.653.30K
Oct 13, 20263.733.733.673.671.40K
Oct 12, 20263.793.803.553.793.40K
Oct 9, 20263.743.883.533.855.70K
Oct 8, 20263.813.813.813.810
Oct 7, 20263.813.813.813.81400
Oct 6, 20264.114.113.763.784.80K
Oct 5, 20263.923.923.923.92800
Oct 2, 20263.913.913.913.910
Oct 1, 20263.913.913.913.910
Sep 30, 20264.084.083.913.911.80K
Sep 29, 20263.883.903.753.90700
Sep 28, 20263.923.923.863.862.30K
Sep 25, 20264.304.304.304.300
Sep 24, 20264.304.304.304.300
Sep 23, 20264.304.304.304.30300
Sep 22, 20264.264.264.264.261.00K
Sep 21, 20264.084.093.973.994.00K

About Molecular Partners Ag

Molecular Partners Ag (MOLN) is listed on the Nasdaq and classified by the SEC under β€œBiological Products, (No Diagnostic Substances)”. Its business address is in Schlieren-Zurich, Switzerland. State of incorporation: Switzerland. Fiscal year ends December 31. SEC CIK 1745114.

MOLN board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

MOLN financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

MOLN earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Biological Products, (No Diagnostic Substances)

Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on MOLN

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.